Published: 14:23, July 22, 2022 | Updated: 18:51, July 24, 2022
Mainland, HKSAR renew TCM cooperation agreement
By Wang Zhan

This undated file photo shows staff members weighing herbal ingredients at the Chinese Medical Clinic of Tung Wah Group Hospitals in Hong Kong. (PHOTO / HKSAR GOVERNMENT)

HONG KONG - The mainland and Hong Kong Special Administrative Region government renewed on Friday the five-year cooperation framework agreement on the research and application of standards of Chinese medicine.

READ MORE: Expert calls for bigger role for TCM in HK's virus battle

The agreement was signed by Hong Kong’s Department of Health and Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences, a subsidiary organization under the National Administration of Traditional Chinese Medicine. The deal is expected to deepen the cooperation and exchanges between the two sides in Chinese medicine and promote the development of Chinese medicine in the two places, a spokesman for the HKSAR government said in a statement.

With the support of relevant mainland units, Hong Kong's research work on Chinese medicines has proceeded smoothly.

Spokesman, HKSAR government 

The HKSAR government has been actively promoting exchanges and cooperation with relevant mainland institutions in the field of Chinese medicine testing and reference standard research, the spokesman said.

“With the support of relevant units such as NATCM and the National Medical Products Administration, Hong Kong's research work on Chinese medicines has proceeded smoothly,” the spokesman added.

The Department of Health and the Institute of Chinese Materia Medica have been working closely since 2017 in research and testing of Chinese medicine standards. In addition to providing technical advice on research work of the deoxyribonucleic acid laboratory in the temporary Government Chinese Medicines Testing Institute at the Hong Kong Science Park, the institute has also co-organized seminars on the development of DNA testing methods to meet the needs of the Chinese medicine market in Hong Kong, according to the spokesman.

ALSO READ: More TCM services for COVID-19 patients in city

“The cooperation agreement signed today will continue the good cooperation relationship between the two parties and jointly foster development in testing and reference standard research of Chinese medicines.”

Under the cooperation agreement, the Department of Health will work with the institute to ensure the quality and safety of Chinese medicines in Hong Kong. The two sides will continue to promote exchanges and cooperation on testing technology of Chinese medicines. They will also promote application of Chinese medicine standards through different activities such as expert group meetings, symposiums and training.